{"doi":"10.1101/2023.08.11.552990","title":"Small molecule nitroalkenes inhibit RAD51-mediated homologous recombination and amplify triple-negative breast cancer cell killing by DNA-directed therapies","abstract":"ABSTRACT Nitro fatty acids (NO 2 -FAs) are endogenously generated lipid signaling mediators from metabolic and inflammatory reactions between conjugated diene fatty acids and nitric oxide or nitrite-derived reactive species. NO 2 -FAs undergo reversible Michael addition with hyperreactive protein cysteine thiolates to induce posttranslational protein modifications that can impact protein function. Herein, we report a novel mechanism of action of natural and non-natural nitroalkenes structurally similar to ( E ) 10-nitro-octadec-9-enoic acid (CP-6), recently de-risked by preclinical Investigational New Drug-enabling studies and Phase 1 and Phase 2 clinical trials and found to induce DNA damage in a TNBC xenograft by inhibiting homologous-recombination (HR)-mediated repair of DNA double-strand breaks (DSB). CP-6 specifically targets Cys319, essential in RAD51-controlled HR-mediated DNA DSB repair in cells. A nitroalkene library screen identified two structurally different nitroalkenes, a non-natural fatty acid [( E ) 8-nitro- nonadec-7-enoic acid (CP-8)] and a dicarboxylate ester [dimethyl ( E )nitro-oct-4-enedioate (CP- 23)] superior to CP-6 in TNBC cells killing, synergism with three different inhibitors of the poly ADP-ribose polymerase (PARP) and γ-IR. CP-8 and CP-23 effectively inhibited γ-IR-induced RAD51 foci formation and HR in a GFP-reported assay but did not affect benign human epithelial cells or cell cycle phases. In vivo, CP-8 and CP-23’s efficacies diverged as only CP-8 showed promising anticancer activities alone and combined with the PARP inhibitor talazoparib in an HR-proficient TNBC mouse model. As preliminary preclinical toxicology analysis also suggests CP-8 as safe, our data endorse CP-8 as a novel anticancer molecule for treating cancers sensitive to homologous recombination-mediated DNA repair inhibitors. Graphical Abstract","journal":"bioRxiv (Cold Spring Harbor Laboratory)","year":2023,"id":410385,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9571,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2023-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1098787,"name":"Dennis Braden","orcid":"0000-0002-2200-805X","position":1,"is_corresponding":false},{"id":1098788,"name":"Yaoning Zhao","orcid":"0009-0000-2081-9433","position":2,"is_corresponding":false},{"id":420471,"name":"John Skoko","orcid":"0000-0002-1885-6929","position":3,"is_corresponding":false},{"id":1016687,"name":"Fei Chang","orcid":"0000-0002-3724-2455","position":4,"is_corresponding":false},{"id":750828,"name":"Steven R. Woodcock","orcid":"0000-0002-4075-1883","position":5,"is_corresponding":false},{"id":1099166,"name":"Crystall Uvalle","orcid":null,"position":6,"is_corresponding":false},{"id":1098789,"name":"Allison N. Casey","orcid":"0000-0003-0626-9361","position":7,"is_corresponding":false},{"id":507103,"name":"Katherine C. Wood","orcid":"0000-0001-9226-0077","position":8,"is_corresponding":false},{"id":323974,"name":"Sonia R. Salvatore","orcid":"0000-0002-9942-3905","position":9,"is_corresponding":false},{"id":892946,"name":"Alparslan Asan","orcid":"0000-0003-2495-5875","position":10,"is_corresponding":false},{"id":893526,"name":"Trey Harkness","orcid":null,"position":11,"is_corresponding":false},{"id":768060,"name":"Adeola A Fagunloye","orcid":"0000-0003-2383-9469","position":12,"is_corresponding":false},{"id":1057235,"name":"Mortezaali Razzaghi","orcid":"0000-0002-5048-3624","position":13,"is_corresponding":false},{"id":351853,"name":"Adam C. Straub","orcid":"0000-0003-0542-9466","position":14,"is_corresponding":false},{"id":273535,"name":"Maria Spies","orcid":"0000-0002-7375-8037","position":15,"is_corresponding":false},{"id":1068662,"name":"Daniel D. Brown","orcid":"0000-0002-7410-9514","position":16,"is_corresponding":false},{"id":44717,"name":"Adrian V. Lee","orcid":"0000-0001-9917-514X","position":17,"is_corresponding":false},{"id":323978,"name":"Francisco J. Schöpfer","orcid":"0000-0001-9526-695X","position":18,"is_corresponding":false},{"id":14608,"name":"Bruce Α. Freeman","orcid":"0000-0002-2028-8369","position":19,"is_corresponding":false},{"id":274110,"name":"Carola A. Neumann","orcid":"0000-0003-2801-9531","position":20,"is_corresponding":false},{"id":345751,"name":"Lisa Hong","orcid":"0000-0003-1667-5400","position":0,"is_corresponding":true}],"reference_count":86,"raw_metadata":null,"created_at":"2026-07-19T01:21:35.071397Z","pmid":"37645906","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}